Abiopharma

BioCorRx Inc., through its subsidiaries, develops innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Companys majority owned subsidiary BioCorRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company engaged in the research and development of treatments for addiction and other related disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com.

Additional info from OTC:
BioCorRx Inc., through its subsidiaries, develops innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Companys majority owned subsidiary BioCorRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company engaged in the research and development of treatments for addiction and other related disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com.